Assessment of the antinociceptive and ulcerogenic activity of the tapentadol–diclofenac combination in rodents

Publisher： John Wiley & Sons Inc

E-ISSN： 1098-2299|79|1|38-44

ISSN： 0272-4391

Source： DRUG DEVELOPMENT RESEARCH, Vol.79, Iss.1, 2018-02, pp. : 38-44

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effectiveness and Safety of Tapentadol Prolonged Release (PR) Versus a Combination of Tapentadol PR and Pregabalin for the Management of Severe, Chronic Low Back Pain With a Neuropathic Component: A Randomized, Double‐blind, Phase 3b Study

By  

PAIN PRACTICE, Vol. 15, Iss. 5, 2015-06 ,pp. : 455-470

John Wiley & Sons Inc

Access to resources Recommend Favorite

Extinction of LINE-1 activity coincident with a major mammalian radiation in rodents

By  

Cytogenetic and Genome Research, Vol. 110, Iss. 1-4, 2005-07 ,pp. : 407-415

Karger

Access to resources Recommend Favorite

Tapentadol ‐ the evidence so far

By  

ANAESTHESIA, Vol. 70, Iss. 5, 2015-05 ,pp. : 518-522

John Wiley & Sons Inc

Access to resources Recommend Favorite

Triple reuptake inhibitors reduce neuropathic pain

By  

EUROPEAN JOURNAL OF PAIN (ELECTRONIC), Vol. 19, Iss. 3, 2015-03 ,pp. : 322-333

John Wiley & Sons Inc

Access to resources Recommend Favorite

Evaluation of the effect of quercetin treatment on CYP2C9 enzyme activity of diclofenac in healthy human volunteers

By  

PHYTOTHERAPY RESEARCH, Vol. 32, Iss. 2, 2018-02 ,pp. : 305-311

John Wiley & Sons Inc

Access to resources Recommend Favorite